NDC 31260-402 - SUCRALFATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 31260-402
- Package NDCs from labels
- 31260-402-01, 31260-402-02
- Manufacturer
- Gulbrandsen Technologies India Private Limited
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SUCRALFATE - Gulbrandsen Technologies India Private Limited | Gulbrandsen Technologies India Private Limited | 2026-04-03 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 31260-402-01 | SUCRALFATE | 25 kg in 1 DRUM | POWDER | 25 | 3 | |
| 31260-402-02 | SUCRALFATE | 0.5 kg in 1 CONTAINER | POWDER | 0.5 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sucralfate | SUCRALFATE | Northwind Health Company, LLC | f3095db3-fd02-873c-e053-2a95a90a5b1f | 2026-01-01 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | TruPharma, LLC | 7d441128-45d2-4bf2-817b-665784992e90 | 2025-12-29 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Northwind Health Company, LLC | 464bf611-4dbb-4707-b9dd-39ca178ed4bf | 2025-12-26 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Redpharm Drug | 3251e156-4c52-63b3-e063-6294a90a9a95 | 2025-12-18 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | AvKARE | c019bf24-8273-8d2f-e053-2a95a90aec98 | 2025-12-03 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | AvPAK | e78ef7d4-faa7-aebf-e053-2995a90a6f84 | 2025-12-03 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Torrent Pharmaceuticals Limited | dc361b46-fda4-4b0b-9950-e8885ba5b084 | 2025-08-21 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Mylan Institutional Inc. | 989ca8a8-3ad6-4ee4-aa9c-eed731828753 | 2025-07-22 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Kesin Pharma Corporation | 36d940f2-207b-68c5-e063-6294a90a6b4a | 2025-07-01 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | NCS HealthCare of KY, LLC dba Vangard Labs | d67dcaad-56c1-4e77-a0c8-655970808414 | 2025-06-13 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | a73010fb-960c-4567-8ab1-6d902fee2c14 | 2025-06-02 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | ATLANTIC BIOLOGICALS CORP. | e5073597-ac51-4e7c-a9dc-7695773a01f1 | 2025-05-27 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Richmond Pharmaceuticals, Inc. | 7ac10c3f-9d50-4702-900c-41075ac6f896 | 2025-05-23 | Warnings, Adverse reactions | XX73205DH5 |
| sucralfate | SUCRALFATE | Bryant Ranch Prepack | abc44549-ac41-4aef-9b15-2ba536e1555f | 2025-05-09 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | NuCare Pharmaceuticals, Inc. | 31a7dcd0-e677-249a-e063-6294a90a75f6 | 2025-03-19 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Coupler LLC | 2d586736-73ae-9af0-e063-6294a90ad875 | 2025-02-04 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | Precision Dose, Inc. | 0dc592e9-541c-4fac-8ab5-829d43521c01 | 2025-01-28 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Direct_Rx | f5f0fecb-949c-3998-e053-2a95a90aac8c | 2025-01-22 | Adverse reactions | XX73205DH5 |
| SUCRALFATE | SUCRALFATE | DIRECT RX | c50b5044-31ed-672a-e053-2995a90a49fc | 2025-01-20 | Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | NuCare Pharmaceuticals,Inc. | 0206d7fa-a1d5-35d9-e063-6294a90a5eb3 | 2025-01-03 | Adverse reactions | XX73205DH5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.